Molecular therapy of breast cancer :
Lacroix, Marc, 1963-
Molecular therapy of breast cancer : classicism meets modernity / Marc Lacroix. - New York : Nova Biomedical Books, c2009. - viii, 291 p. ; 27 cm. - Cancer etiology, diagnosis and treatments series . - Cancer etiology, diagnosis, and treatments. .
Includes bibliographical references and index.
Introduction -- Selective estrogen receptor modulators (SERMs) and down-regulators (SERDs) -- Aromatase inhibitors -- Agents inducing ovarian suppression -- Antimetabolites -- Alkylating agents -- Anthracyclines -- Microtubule-binding agents -- Topoisomerase inhibitors -- HER family inhibitors -- Angiogenesis inhibitors -- Insulin-like growth factor-I receptor (IGF-1R) inhibitors -- Ras-Raf-MEK-ERK pathway inhibitors -- Ubiquitin-proteasome system inhibitors -- Histone deacetylases inhibitors -- Mitotic inhibitors -- Inhibitors of heat-shock proteins 90 and 27 -- PI3K/Akt/mTOR pathway inhibitors -- Cyclooxygenase-2 inhibitors -- Poly(ADP-Ribose) polymerase (PARP)-1 inhibitors -- Tumor-induced osteolysis inhibitors -- Vaccines and immunomodulators -- Varia.
9781607415930 (hardcover : alk. paper) 1607415933 (hardcover : alk. paper)
2009013524
101500490 DNLM
Breast--Cancer--Molecular aspects.
Antineoplastic agents.
Breast Neoplasms--drug therapy.
Antineoplastic Agents--therapeutic use.
Enzyme Inhibitors--therapeutic use.
RC280.B8 / L2715 2009
362.19699449/ / LAC
Molecular therapy of breast cancer : classicism meets modernity / Marc Lacroix. - New York : Nova Biomedical Books, c2009. - viii, 291 p. ; 27 cm. - Cancer etiology, diagnosis and treatments series . - Cancer etiology, diagnosis, and treatments. .
Includes bibliographical references and index.
Introduction -- Selective estrogen receptor modulators (SERMs) and down-regulators (SERDs) -- Aromatase inhibitors -- Agents inducing ovarian suppression -- Antimetabolites -- Alkylating agents -- Anthracyclines -- Microtubule-binding agents -- Topoisomerase inhibitors -- HER family inhibitors -- Angiogenesis inhibitors -- Insulin-like growth factor-I receptor (IGF-1R) inhibitors -- Ras-Raf-MEK-ERK pathway inhibitors -- Ubiquitin-proteasome system inhibitors -- Histone deacetylases inhibitors -- Mitotic inhibitors -- Inhibitors of heat-shock proteins 90 and 27 -- PI3K/Akt/mTOR pathway inhibitors -- Cyclooxygenase-2 inhibitors -- Poly(ADP-Ribose) polymerase (PARP)-1 inhibitors -- Tumor-induced osteolysis inhibitors -- Vaccines and immunomodulators -- Varia.
9781607415930 (hardcover : alk. paper) 1607415933 (hardcover : alk. paper)
2009013524
101500490 DNLM
Breast--Cancer--Molecular aspects.
Antineoplastic agents.
Breast Neoplasms--drug therapy.
Antineoplastic Agents--therapeutic use.
Enzyme Inhibitors--therapeutic use.
RC280.B8 / L2715 2009
362.19699449/ / LAC